TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential
Open Access
- 27 September 2024
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 264 (3) , 318-331
Abstract
Telomerase reverse transcriptase (TERT) gene aberration is detectable in >80% of cases with hepatocellular carcinoma (HCC). TERT reactivation is essential for cellular immortalization because it stabilizes telomere length, although the role of TERT in hepatocarcinogenesis remains unelucidated. To elucidate the significance of aberrant TERT expression in hepatocytes in inflammation‐associated hepatocarcinogenesis, we generated Alb‐Cre;TertTg mice, which overexpress TERT in the liver and examined their phenotype during chronic inflammation. Based on transcriptome data from the liver tissue of Alb‐Cre;TertTg mice, we examined the role of TERT in hepatocarcinogenesis in vitro. We also evaluated the relationship between TERT and cell‐cycle‐related molecules, including p21, in HCC samples. The liver tumor development rate was increased by TERT overexpression during chronic inflammation, especially in the absence of p53 function. Gene set enrichment analysis of liver tissues revealed that gene sets related to TNF‐NFκB signaling, cell cycle, and apoptosis were upregulated in Alb‐Cre;TertTg liver. A luciferase reporter assay and immunoprecipitation revealed that TERT interacted with NFκB p65 and enhanced NFκB promoter activity. On the other hand, TERT formed protein complexes with p21, cyclin A2, and cyclin E and promoted ubiquitin‐mediated degradation of p21, specifically in the G1 phase. In the clinical HCC samples, TERT was highly expressed but p21 was conversely downregulated, and TERT expression was associated with the upregulation of molecules related to the cell cycle. Taken together, the aberrant upregulation of TERT increased NFκB promoter activity and promoted cell cycle progression via p21 ubiquitination, leading to hepatocarcinogenesis. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Japan Society for the Promotion of Science (17H04158, 19K08443, 21K07912, 22K07983, 22K15964)
This publication has 48 references indexed in Scilit:
- Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathwaysBiochimie, 2021
- Multiregional whole‐genome sequencing of hepatocellular carcinoma with nodule‐in‐nodule appearance reveals stepwise cancer evolutionThe Journal of Pathology, 2020
- Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosisJournal of Gastroenterology, 2019
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisHepatology, 2014
- Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular studyThe Lancet Oncology, 2013
- Mammalian cyclin-dependent kinasesTrends in Biochemical Sciences, 2005
- Ubiquitination of p21Cip1/WAF1 by SCFSkp2: Substrate Requirement and Ubiquitination Site SelectionBiochemistry, 2005
- Proteasome-Mediated Degradation of p21 via N-Terminal UbiquitinylationCell, 2003
- p21: structure and functions associated with cyclin-CDK binding1997
- Telomeres: No end in sightCell, 1994